Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4

Journal of Pharmacology and Experimental Therapeutics

Volumn 302, Issue 3, 2002, Pages 881-888

  Perry, Tracyann ^a,b   Haughey, Norman J ^a   Mattson, Mark P ^a   Egan, Josephine M ^a   Greig, Nigel H ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE ACETYLTRANSFERASE; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; GLUCOSE; GLUTAMIC ACID; IBOTENIC ACID; NEUROPROTECTIVE AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CENTRAL NERVOUS SYSTEM; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DIABETIC NEUROPATHY; EMBRYO; FOOD; FOREBRAIN; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOREACTIVITY; INSULIN RELEASE; MALE; NERVE CELL LESION; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; BASAL GANGLIA; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CHOLINE O-ACETYLTRANSFERASE; CYCLIC AMP; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUTAMIC ACID; HIPPOCAMPUS; IBOTENIC ACID; IMMUNOHISTOCHEMISTRY; NERVE DEGENERATION; NEURONS; PARASYMPATHETIC NERVOUS SYSTEM; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN PRECURSORS; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCAGON; VENOMS;

EID: 0036721026     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.037481     Document Type: Article

References (43)

1. Estimation of nuclear population from microtome sections
2. Structural characterization by affinity cross-linking of glucagon-like peptide-1(7-36)amide receptor in rat brain
3. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse
4. Neurotrophin-4/5 protects hippocampal and cortical neurons against energy deprivation- and excitatory amino acid-induced injury
5. Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain
6. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats
7. Glucagon-like peptide-1
8. The insulinotropic effect of acute Exendin-4 administration to humans: Comparison of nondiabetic state to type 2 diabetes
9. Cortical cholinergic fibers in aging and Alzheimer's disease: A morphometric study
10. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin- secreting beta-cells
11. Distribution of GLP-1 binding sites in the rat brain: Evidence that exendin-4 is a ligand of brain GLP-1 binding sites
12. Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations
13. Central glucagon-like peptide-I in the control of feeding
14. Role of NGF in axotomy-induced c-Jun expression in medial septal cholinergic neurons
15. Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor
16. Distribution ofglucagonlike peptide I (GLP-I), glucagon and glicentin in the rat brain: An immunocytochemical study
17. Identification and characterization of glucagon-like peptide-1 7-36 amide-binding sites in the rat brain and lung
18. Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment
19. Spatial learning in rats: Correlation with cortical choline acetyltransferase and improvement with NGF following NBM damage
20. Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons
21. Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat
22. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system
23. Overexpression of glucagon-like peptide-1 receptor in an insulin-secreting cell line enhances glucose responsiveness
24. High potency antagonists of the pancreatic glucagon-like peptide-1 receptor
25. Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I
26. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer′s disease
27. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell deathvia corticotropin-releasing hormone receptor type I
28. Glucagon-like peptide- 1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats
29. Behavioural, histological and immunocyto-chemical consequences following 192 IgG-saporin immunolesions of the basal forebrain cholinergic system
30. A novel neurotrophic property of glucagon-like peptide 1: A promoter of nerve growth factor-mediated differentiation in PC12 cells
31. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia
32. Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: Lack of coupling to either stimulation or inhibition of adenylyl cyclase
33. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene
34. Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice
35. Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus
36. Central administration ofGLP-1-(7-36) amide inhibits food and water intake in rats
37. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor
38. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system
39. A role for glucagon-like peptide-1 in the central regulation of feeding
40. Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats
41. Tissue-specific expression of the human receptor for glucagon-like peptide-1: Brain, heart and pancreatic forms have the same deduced amino acid sequences
42. Nerve growth factor and glial cell line derived neurotrophic factor restore the cholinergic neuronal phenotype in organotypic brain slices of the basal nucleus of Meynert